Literature DB >> 19237549

Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.

Dina Schneider1, Maria A Manzan, Byung Sun Yoo, Robert B Crawford, Norbert Kaminski.   

Abstract

B cell differentiation and humoral immune responses are markedly suppressed by the persistent environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The suppression of humoral immune responses by TCDD occurs by direct actions on the B cell and involves activation of the aryl hydrocarbon receptor. Transcriptional regulation of paired box gene 5 (Pax5), an important regulator of B cell differentiation, is altered by TCDD in concordance with the suppression of B cell differentiation and humoral immunoglobulin M response. We hypothesized that TCDD treatment leads to dysregulation of Pax5 transcription by interfering with the basic B cell differentiation mechanisms and aimed to determine the effects of TCDD on upstream regulators of Pax5. A critical regulator of B cell differentiation, B lymphocyte-induced maturation protein-1 (Blimp-1) acts as a transcriptional repressor of Pax5. In lipopolysaccharide (LPS)-activated murine B cell lymphoma, CH12.LX, Blimp-1 messenger RNA, and DNA-binding activity within the Pax5 promoter were suppressed by TCDD. Furthermore, LPS activation of CH12.LX cells upregulated DNA-binding activity of activator protein 1 (AP-1) at three responsive element-like motifs within the Blimp-1 promoter. TCDD treatment of LPS-activated CH12.LX cells suppressed AP-1 binding to these motifs between 24 and 72 h, in concordance with the suppression of Blimp-1 by TCDD. A more comprehensive analysis at 72 h demonstrated that the suppression of AP-1 binding within the Blimp-1 promoter by TCDD was concentration dependent. In summary, our findings link the TCDD-mediated suppression of Blimp-1 through AP-1 to the dysregulation of Pax5, which ultimately leads to the suppression of B cell differentiation and humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237549      PMCID: PMC2664693          DOI: 10.1093/toxsci/kfp028

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  40 in total

1.  An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene.

Authors:  J L Rinkenberger; J J Wallin; K W Johnson; M E Koshland
Journal:  Immunity       Date:  1996-10       Impact factor: 31.745

Review 2.  AP-1 function and regulation.

Authors:  M Karin; Z g Liu; E Zandi
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

3.  Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.

Authors:  C E Sulentic; M P Holsapple; N E Kaminski
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

4.  A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation.

Authors:  Yusuke Ohkubo; Masafumi Arima; Eggi Arguni; Seiji Okada; Kimihiro Yamashita; Sadaki Asari; Shintaro Obata; Akemi Sakamoto; Masahiko Hatano; Jiyang O-Wang; Masaaki Ebara; Hiromitsu Saisho; Takeshi Tokuhisa
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

Review 5.  Terminal differentiation of lymphocytes depends on Blimp-1.

Authors:  Axel Kallies; Stephen L Nutt
Journal:  Curr Opin Immunol       Date:  2007-02-08       Impact factor: 7.486

Review 6.  Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms.

Authors:  S Safe; F Wang; W Porter; R Duan; A McDougal
Journal:  Toxicol Lett       Date:  1998-12-28       Impact factor: 4.372

7.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.

Authors:  Dina Schneider; Maria A Manzan; Robert B Crawford; Weimin Chen; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2008-05-15       Impact factor: 4.030

8.  Human BSAP and BLIMP1 conform an autoregulatory feedback loop.

Authors:  Francisco Mora-López; Elena Reales; José A Brieva; Antonio Campos-Caro
Journal:  Blood       Date:  2007-08-06       Impact factor: 22.113

9.  Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1.

Authors:  A M Reimold; P D Ponath; Y S Li; R R Hardy; C S David; J L Strominger; L H Glimcher
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion.

Authors:  David Savitsky; Kathryn Calame
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

View more
  17 in total

1.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells.

Authors:  Haitian Lu; Robert B Crawford; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2011-07-21       Impact factor: 4.219

2.  2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.

Authors:  Colin M North; Robert B Crawford; Haitian Lu; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2010-03-26       Impact factor: 4.849

3.  The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene.

Authors:  Michael J Wourms; Courtney E W Sulentic
Journal:  Cell Immunol       Date:  2015-02-26       Impact factor: 4.868

4.  An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.

Authors:  K Nadira De Abrew; Norbert E Kaminski; Russell S Thomas
Journal:  Toxicol Sci       Date:  2010-09-06       Impact factor: 4.849

5.  Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  K Nadira De Abrew; Ashwini S Phadnis; Robert B Crawford; Norbert E Kaminski; Russell S Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-04       Impact factor: 4.219

6.  Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant.

Authors:  Zhiqing Duan; Yunqing Duan; Huangui Lei; Ningzhu Hu; Jiandong Shi; Dong Shen; Xi Wang; Yunzhang Hu
Journal:  Hum Vaccin Immunother       Date:  2014-02-28       Impact factor: 3.452

7.  Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.

Authors:  Qiang Zhang; Sudin Bhattacharya; Douglas E Kline; Robert B Crawford; Rory B Conolly; Russell S Thomas; Norbert E Kaminski; Melvin E Andersen
Journal:  BMC Syst Biol       Date:  2010-04-01

8.  The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.

Authors:  Lionel Apetoh; Francisco J Quintana; Caroline Pot; Nicole Joller; Sheng Xiao; Deepak Kumar; Evan J Burns; David H Sherr; Howard L Weiner; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2010-08-01       Impact factor: 25.606

9.  All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Qiang Zhang; Douglas E Kline; Sudin Bhattacharya; Robert B Crawford; Rory B Conolly; Russell S Thomas; Melvin E Andersen; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-26       Impact factor: 4.219

10.  Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response.

Authors:  Colin M North; Robert B Crawford; Haitian Lu; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2009-08-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.